These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 17567605)
1. DSIF contributes to transcriptional activation by DNA-binding activators by preventing pausing during transcription elongation. Zhu W; Wada T; Okabe S; Taneda T; Yamaguchi Y; Handa H Nucleic Acids Res; 2007; 35(12):4064-75. PubMed ID: 17567605 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional pausing caused by NELF plays a dual role in regulating immediate-early expression of the junB gene. Aida M; Chen Y; Nakajima K; Yamaguchi Y; Wada T; Handa H Mol Cell Biol; 2006 Aug; 26(16):6094-104. PubMed ID: 16880520 [TBL] [Abstract][Full Text] [Related]
3. The small hSpt4 subunit of the human transcription elongation factor DSIF is a Zn-finger protein with alpha/beta type topology. Wenzel S; Schweimer K; Rösch P; Wöhrl BM Biochem Biophys Res Commun; 2008 Jun; 370(3):414-8. PubMed ID: 18373978 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the human transcription elongation factor DSIF hSpt4 subunit in complex with the hSpt5 dimerization interface. Wenzel S; Martins BM; Rösch P; Wöhrl BM Biochem J; 2009 Dec; 425(2):373-80. PubMed ID: 19860741 [TBL] [Abstract][Full Text] [Related]
5. The transcription elongation factors NELF, DSIF and P-TEFb control constitutive transcription in a gene-specific manner. Fujita T; Piuz I; Schlegel W FEBS Lett; 2009 Sep; 583(17):2893-8. PubMed ID: 19654008 [TBL] [Abstract][Full Text] [Related]
6. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. Wada T; Takagi T; Yamaguchi Y; Watanabe D; Handa H EMBO J; 1998 Dec; 17(24):7395-403. PubMed ID: 9857195 [TBL] [Abstract][Full Text] [Related]
7. Transcription elongation factors are involved in programming hormone production in pituitary neuroendocrine GH4C1 cells. Fujita T; Piuz I; Schlegel W Mol Cell Endocrinol; 2010 May; 319(1-2):63-70. PubMed ID: 20097260 [TBL] [Abstract][Full Text] [Related]
8. Role of human transcription elongation factor DSIF in the suppression of senescence and apoptosis. Komori T; Inukai N; Yamada T; Yamaguchi Y; Handa H Genes Cells; 2009 Mar; 14(3):343-54. PubMed ID: 19210550 [TBL] [Abstract][Full Text] [Related]
9. Interactions between DSIF (DRB sensitivity inducing factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II transcription elongation complex. Missra A; Gilmour DS Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11301-6. PubMed ID: 20534440 [TBL] [Abstract][Full Text] [Related]
10. Identification of Regions in the Spt5 Subunit of DRB Sensitivity-inducing Factor (DSIF) That Are Involved in Promoter-proximal Pausing. Qiu Y; Gilmour DS J Biol Chem; 2017 Mar; 292(13):5555-5570. PubMed ID: 28213523 [TBL] [Abstract][Full Text] [Related]
11. Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Yamaguchi Y; Inukai N; Narita T; Wada T; Handa H Mol Cell Biol; 2002 May; 22(9):2918-27. PubMed ID: 11940650 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat: coping with negative elongation factors. Garber ME; Jones KA Curr Opin Immunol; 1999 Aug; 11(4):460-5. PubMed ID: 10448148 [TBL] [Abstract][Full Text] [Related]
14. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Wada T; Takagi T; Yamaguchi Y; Ferdous A; Imai T; Hirose S; Sugimoto S; Yano K; Hartzog GA; Winston F; Buratowski S; Handa H Genes Dev; 1998 Feb; 12(3):343-56. PubMed ID: 9450929 [TBL] [Abstract][Full Text] [Related]
15. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. Ping YH; Rana TM J Biol Chem; 2001 Apr; 276(16):12951-8. PubMed ID: 11112772 [TBL] [Abstract][Full Text] [Related]
16. Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex. Narita T; Yamaguchi Y; Yano K; Sugimoto S; Chanarat S; Wada T; Kim DK; Hasegawa J; Omori M; Inukai N; Endoh M; Yamada T; Handa H Mol Cell Biol; 2003 Mar; 23(6):1863-73. PubMed ID: 12612062 [TBL] [Abstract][Full Text] [Related]
17. P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation. Yamada T; Yamaguchi Y; Inukai N; Okamoto S; Mura T; Handa H Mol Cell; 2006 Jan; 21(2):227-37. PubMed ID: 16427012 [TBL] [Abstract][Full Text] [Related]
18. A mediator required for activation of RNA polymerase II transcription in vitro. Flanagan PM; Kelleher RJ; Sayre MH; Tschochner H; Kornberg RD Nature; 1991 Apr; 350(6317):436-8. PubMed ID: 2011193 [TBL] [Abstract][Full Text] [Related]
19. Structure-function analysis of human Spt4: evidence that hSpt4 and hSpt5 exert their roles in transcriptional elongation as parts of the DSIF complex. Kim DK; Inukai N; Yamada T; Furuya A; Sato H; Yamaguchi Y; Wada T; Handa H Genes Cells; 2003 Apr; 8(4):371-8. PubMed ID: 12653964 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation domains stimulate initiation and elongation at different times and via different residues. Brown SA; Weirich CS; Newton EM; Kingston RE EMBO J; 1998 Jun; 17(11):3146-54. PubMed ID: 9606196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]